Jul 2, 2026 04:19AM
Jun 29, 2026 07:01AM
Jun 29, 2026 07:00AM
Jun 8, 2026 07:31AM
Jun 8, 2026 07:30AM
May 12, 2026 04:05PM
May 12, 2026 06:00AM Neurogene Highlights Data at ASGCT Meeting Supporting Therapeutic Rationale for ICV Delivery Method in CNS-targeted Gene Therapy
Apr 28, 2026 07:30AM
Mar 24, 2026 10:28AM
Mar 24, 2026 07:30AM
Feb 26, 2026 04:01PM
Feb 26, 2026 04:01PM
Jan 12, 2026 07:00AM
Jan 12, 2026 07:00AM Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome
Nov 13, 2025 05:10PM
Nov 12, 2025 04:01PM
Nov 6, 2025 07:30AM
Oct 9, 2025 07:01AM
Oct 9, 2025 07:00AM
Oct 3, 2025 06:43AM
Aug 14, 2025 08:01AM Stifel Reiterates Buy Rating on Neurogene (NGNE)
Aug 11, 2025 04:10PM
Jul 1, 2025 08:21AM
Jun 30, 2025 04:02PM
Jun 30, 2025 04:01PM
Jun 17, 2025 09:17AM
Jun 5, 2025 12:44PM
May 19, 2025 12:29PM Neurogene (NGNE) PT Raised to $22 at BMO Capital
May 16, 2025 03:35AM
May 9, 2025 07:30AM
Apr 28, 2025 05:00PM
Apr 2, 2025 04:01PM
Apr 2, 2025 04:01PM
Mar 24, 2025 04:10PM
Nov 25, 2024 06:47AM H.C. Wainwright Reiterates Buy Rating on Neurogene (NGNE)
Nov 20, 2024 04:54PM
Nov 19, 2024 04:02PM
Nov 19, 2024 11:07AM
Nov 18, 2024 05:25PM
Nov 18, 2024 06:45AM
Nov 18, 2024 06:45AM
Nov 11, 2024 04:01PM Neurogene (NGNE) Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
Nov 11, 2024 04:01PM
Aug 14, 2024 10:14AM
Aug 9, 2024 07:30AM
Aug 7, 2024 07:30AM
Aug 7, 2024 07:30AM
Jul 12, 2024 07:49AM
Jul 1, 2024 07:30AM Neurogene Announces Addition to Russell 3000® Index
Jun 18, 2024 09:26AM

325,594 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All